Medfield Diagnostics AB (publ)

NGM:MEDF Voorraadrapport

Marktkapitalisatie: SEK 23.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Medfield Diagnostics Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bjorn Larsson

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur1.3yrs

Recente managementupdates

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

CEO

Bjorn Larsson

less than a year

Tenure

Mr. Björn Larsson served as Chief Executive Officer at RLS Global AB (publ) since October 01, 2022 until July 2023 and was its Member of Management Board since 2022 until July 2023. He serves as Chief Exec...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Bjorn Larsson
CEO & Director1.8yrsgeen gegevensgeen gegevens
Wigge Jacobsson
Directorno dataSEK 58.35k0.0096%
SEK 2.3k
Mats Andersson
Chairman of the Boardless than a yeargeen gegevens0.0013%
SEK 297.9
Goran Roos
Independent Director1.8yrsgeen gegevensgeen gegevens
Mikael Elam
Directorless than a yeargeen gegevens0.020%
SEK 4.6k

1.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MEDF wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw bestuur.